References
- Tormey DC, Jordan CV. Long-term tamoxifen adjuvant therapy in node-positive breast cancer: A metabolic and pilot clinical study. Breast Cancer Res Treat 1984; 4: 297–302
- Stewart HJ. The Scottish trial of adjuvant tamoxifen in nodenegative breast cancer. Scottish Cancer Trials Breast Group. Monogr Natl Cancer Inst 1992; 11: 117–120
- Early Breast Cancer Trialists' Collaberative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992; 8785: 71–85, 339:8784:1–14
- Rutqvist LE, Cedermark B, Glau U. Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 1991; 83: 1299–1306
- Anderson M, Storm HH, Mourdisen HT. Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for breast cancer. J Natl Cancer Inst 1991; 83: 1013–1017
- Fisher B, Costantino J, Redmond C. A randomized clinical trial evaluating tamoxifen in the treatment of patients with nodenegative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989; 320: 479–484
- Fornander T, Rutqvist LE, Wilking N. Effect of tamoxifen on the female genital tract. Ann NY Acad Sci 1991; 622: 469–476
- Fornander T, Hellstrom AC, Moberger B. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. J Natl Cancer Inst 1993; 85(22)1850–1855
- Magriples U, Naftolin F, Schwartz PE, Carcangiu ML. Highgrade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 1993; 113: 485–490
- Stewart H, Scottish Trials Breast Group. Personal communication 1993
- Letter to Oncologists. Zeneca Pharmaceuticals April 8, 1994
- Gail M, Brinton L, Byar D. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81: 1879–1884
- Muggia FM, Greenspan EM. Workshop on chemoprevention of breast cancer. Chemotherapy Foundation. Cancer Res 1984; 44: 3151–154
- Vogel V, Anderson M.D., Center Cancer. Personal communication 1993
- Anderson J, Nielsen J, Christensen L. The significance of the frequency and occurrence of breast cancer for treatment: Essential aspects of new Danish studies of the natural history of breast cancer. Acta Chir Belg 1987; 87: 103–107
- Morrow M, Jordan VC. The tamoxifen trial for breast cancer: Clinical issues. Cancer Prev Dec. 1–10, 1992
- Nayfield S, Karp JE, Ford LG, Dorr A. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 1991; 83: 1450–1459
- Gray R. Tamoxifen: How boldly to go where no women have gone before. J Natl Cancer Inst 1993; 85(17)1358–1360
- Love RR. The National Surgical Adjuvant Breast Project (NS-ABP) Breast Cancer Prevention Trial Revisited. Cancer Epidemiol Biomark Prev 1993; 2: 403–407
- Bush TL, Heizisouer KJ. Tamoxifen for the primary prevention of breast cancer: A review and critique of the concept and trial. Epidemiol Rev 1993; 15(1)233–243